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Association between anxiety disorder
and the extent of ischemia observed
in cardiac syndrome X
I.A.C. Vermeltfoort, MD,a P.G.H.M. Raijmakers, MD, PhD,a D.A.M. Odekerken,
MD,b A.F.M. Kuijper, MD, PhD,b A. Zwijnenburg, MD, PhD,c and G.J.J. Teule, MD,
PhDd
Background. A possible link between the heart and brain has been reported for cardiac
syndrome X. Anxiety disorder could be a pathophysiological mechanism for this cardiac chest
pain. To the authors’ knowledge, a quantitative analysis correlating anxiety with the extent of
ischemia has not been done.
Methods and Results. In this pilot study, we evaluated 20 patients with typical chest pain and
completely normal coronary angiograms. These patients were screened with the State Scale and
Trait Scale of the State-Trait Anxiety Inventory (STAI). All patients underwent myocardial per-
fusion scintigraphic imaging. The scintigrams were scored by three experienced readers having no
knowledge of the STAI screening results. Patients with a low trait anxiety had significantly less
ischemic segments on the myocardial perfusion imaging than patients with a high trait anxiety
(1.8 ± 1.9 vs 3.5 ± 0.6, P < .05). For state anxiety, no significant differences could be found.
Conclusion. Cardiac syndrome X patients with high trait anxiety are at risk of having more
ischemia. (J Nucl Cardiol 2009;16:405–10.)
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INTRODUCTION
About 20% of patients with anginal chest pain have
normal coronary angiograms.1,2 The term ‘‘cardiac syn-
drome X’’ (CSX) was introduced to describe these
patients.3,4 A subgroup of these patients has objective signs
of ischemia, such as the classic downsloping ST-segment
depression on exercise testing and/or a reversible defect
detected by myocardial single-photon emission computed
tomography (SPECT).5-9
The pathogenesis of CSX remains uncertain. Two
mechanisms have been proposed: ischemia caused by
coronary microvascular dysfunction, and enhanced car-
diac pain sensitivity (‘‘sensitive heart’’ syndrome).10
Several studies found abnormalities consistent with
ischemia in patients with syndrome X using scintigraphic
myocardial perfusion imaging,5-9 thermodilution,11
nuclear magnetic resonance spectroscopy,12 intracoro-
nary acetylcholine,13,14 atrial pacing,15 and cardiac
magnetic resonance (CMR) imaging.16,17 These CMR
studies support the hypothesis of microvascular ischemia
in CSX patients. There are also PET studies demon-
strating a reduced coronary flow reserve in CSX
patients.18-20 On the other hand, a recent CMR study
found no impairment of subendocardial blood flow
response in CSX patients,21 and a PET study by Rosen
et al showed no differences in myocardial blood flow
between CSX patients and healthy controls.22
In the last few years, attention has been paid to the
effect of psychological factors on coronary artery disease
(e.g., atherosclerosis) and cardiac neural mechanisms.23
Previous work identified the importance of impaired
myocardial blood flow, particularly in the microvascular
bed, in relation to mental stress,24,25 and the phenomenon
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of endothelial dysfunction induced by mental stress has
been described in CSX.26 Furthermore, CSX patients
have significantly higher levels of anxiety.27
Owing to the conflicting data regarding ischemia in
CSX patients, and also the possible role of anxiety, we
performed a pilot study to measure the extent of ische-
mia and anxiety levels in a group of CSX patients.
METHODS
Patients
The pilot study population consisted of 20 patients from
the outpatient clinic of the cardiology department in a general
hospital (February 2004-September 2004). All patients exhib-
ited typical chest pain, positive exercise stress testing (0.1 mV
horizontal or downsloping ST-segment depression of 80 ms
after the J point) and/or a reversible perfusion defect on a
myocardial single photon emission tomograph (SPECT). Fur-
thermore, all patients had completely normal coronary
angiograms (CAGs). This was independently confirmed by two
cardiologists in separate viewing sessions and without clinical
information.
The patients’ characteristics are given in Table 1. None of
the patients had a percutaneous transluminal coronary angio-
plasty (PTCA); coronary artery bypass grafting (CABG) or
prior myocardial infarction; coronary spasm during the coro-
nary angiography; absence of pain without medication;
pregnancy; hypertension (defined as blood pressure over 140/
90 mmHg); diabetes (defined by a fasting glucose level above
7.8 mmol per liter or a random-sample glucose level above
11.1 mmol per liter); arrhythmias such as paroxysmal atrial
fibrillation (PAF); left bundle branch block; valve dysfunction
(other than mitral valve insufficiency grade 1); abnormal left
ventricle ejection fraction (LVEF \ 50%), or other structural
abnormalities of the heart. Also, none of the patients had
electrographic signs of left ventricular hypertrophy (defined as
a value above 35 mm for the sum of the height of the S wave in
lead V1 and the height of the R wave in lead V5),
28 or any
change in clinical condition between the investigations.
The study complied with the Declaration of Helsinki, the
institutional ethics committee approved this study, and all
patients gave written informed consent.
Screening for Anxiety
Patients were recruited for a questionnaire study after
their visit to the outpatient clinic of the cardiology department.
State anxiety was measured by the State Scale (SS) and trait
anxiety by the Trait Scale (TS) of the State-Trait Anxiety
Inventory (STAI Dutch version revised by van der Ploeg,
Defares, and Spielberger).29,30 This self-report scale measures
the current symptoms of anxiety (state scale) and the partici-
pants’ predisposition to anxiety (trait scale). It consists of
2 9 20 self-report items, and earlier use has shown good
internal consistency (a = 0.87-0.92) and validity. For analysis,
the subjects were categorized as having low (score \ 40) or
high (score [ 40) state and trait anxiety.31,32
For all the patients, the questionnaires were supplemented
by reviews of medical records and by a general questionnaire,
including indices of socio-economic status (education, marital
status, and current employment).
Myocardial Perfusion SPECT (Stress-Rest
2 Days Protocol)
The first day was allocated to the stress (exercise) study.
Patients were instructed to stop all cardiac medication 24 hours
before testing, and to have a light breakfast. They had not
consumed caffeine-containing beverages for 24 hours before
the test. An intravenous line of normal saline solution, with a
20-gauge cannula, was positioned in an antecubal vein. The
exercise was performed on a calibrated ergometer using a
symptom-limited test with stepwise increased work. A 12-lead
electrocardiogram and blood pressure were monitored
throughout the study. SPECT imaging was performed 45-
60 minutes after peak exercise radiotracer injection.
On day 2 the patients underwent an at-rest study.
Acquisition parameters were identical to those for the stress
study.
SPECT imaging was performed on a double-headed
gamma camera with a high-resolution collimator. A symmetric
20% window was centered at 140 KeV, with a three-lead
electric cardiographic monitoring. Imaging was acquired into a
64 9 64 computer matrix through a 180 rotation, with 32
positions; starting position is RAO 45, with 8 frames per
cycle. Bull’s-eye generation, and visual analysis using a 19-
segmental model were performed.
Three experienced observers interpreted the SPECT
results. Perfusion was graded on a scale of 0-4, with 0 repre-
senting normal perfusion and 4 representing a very severe
Table 1. Patient’s characteristics
Patient’s characteristics Value
Age, mean ± SD (years) 55 ± 11
Women, n (%) 14 (70%)
Smoker, n (%) 3 (15%)
Hypertension 0 (0%)
CAD in family 13 (65%)
Hyperventilation 1 (5%)
Time between onset angina and first visit
cardiologist, mean ± SD (years)
3.1 ± 8.1
Number of coronary angiograms, mean
±SD
1.2 ± 0.5
Number of patients using cardiac drugs 8 (40%)
Number of patients restricted in daily living
due to angina pectoris
6 (30%)
Number of patients restricted in sport due
to chest pain
5 (25%)
Number of patients experiencing chest
pain during emotional stress
7 (35%)
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perfusion defect. Perfusion defects graded one or more points
below the at-rest SPECT results were considered to be ische-
mic. Consensus was obtained in cases of disagreement. Also,
the observers had not been informed of the STAI results.
Statistical Analysis
Variables like the STAI trait and state score, and the
number of reversible segments in the SPECT study were
expressed as mean ± standard deviation (SD). The numbers of
patients (n) are expressed as absolute values and percentages of
total (%). Variables were contrasted between two groups of
low or high anxiety using an unpaired student test (two-sided),
for both the state and the trait STAI groups. A P value less than
.05 was considered to be significant.
RESULTS
Table 2 lists the state anxiety and trait anxiety
scores and the locations of ischemia on SPECT for all
the patients.
State STAI
Six (6) patients had high state anxiety levels. These
patients had a mean of 3.0 ± 1.6 reversible perfusion
defects on SPECT. This value was not significantly
different from the mean of 2.0 ± 2.0 reversible perfusion
defects for patients with low state anxiety levels.
Trait STAI
Six (6) patients had a high trait anxiety score,
reflecting a high predisposition to anxiety. These
patients had a mean of 3.5 ± 0.6 reversible perfusion
defects on SPECT. This value was significantly different
(P \ .05) from the mean of 1.8 ± 1.9 reversible perfu-
sion defects for patients with low trait anxiety scores.
Figure 1 illustrates this difference.
Cross-Sectional Comparisons between
those with High or Low Trait Anxiety Scores
Table 3 compares the patients with high and low
scores for trait anxiety on the basis of demographic and
medical variables. There is a trend for high trait anxiety
patients to have more frequent chest pain during emo-
tional stress, and they were also more frequently
restricted in daily living as well as in practicing sports.
However, none of the differences were statistically
significant.
Table 2. Anxiety scores and location of ischemia for individual patients
Patients
State
anxiety
Trait
anxiety
Number of ischemic
segments Location of ischemia
1 53 52 3 Anterior (m), apical
2 34 36 1 Anterior (b)
3 20 20 4 Posterolat (b), inferoseptal (b ? m), inferior (m)
4 27 24 0
5 41 40 0
6 51 56 4 Anterior (d), posterolat (b ? m? d)
7 22 23 5 Anterolat (b ? m), anteroseptal (b ? m? d)
8 31 44 3 Inferior (b), anterolat (b), apical
9 52 58 3 Inferior (b ? m), posterolat (b ? m)
10 39 36 5 Inferior (b ? m), posterolat (b ? m)
11 24 26 0
12 33 36 0
13 39 34 2 Inferior (b), posterolat (b)
14 36 29 1 Anteroseptal (b)
15 41 44 4 Anterior (b ? m? d), anteroseptal (d)
16 38 38 4 Anterior (b ? m), apical, anterolat (d)
17 25 22 1 Inferior (b)
18 51 56 4 Posterolat (b), inferior (b ? m), apical
19 24 24 0
20 36 39 2 Anteroseptal (m ? d)
State anxiety is considered increased with scores[40.
Trait anxiety is considered increased with scores[40.
B basal, m mid, d distal segment.
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DISCUSSION
This study demonstrates the association between
high trait anxiety and the extent of ischemia in CSX
patients. This suggests that trait anxiety is associated
with an increased risk of exercise-induced ischemia and
that high trait anxiety might be a predisposing risk factor
for cardiovascular damage causing reversible perfusion
defects on the SPECT imaging of CSX patients.
As mentioned in the introduction to this paper,
attention has recently been paid to the effect of psy-
chological factors on coronary artery disease and cardiac
neural mechanisms.23 Previous work identified the
importance of impaired myocardial blood flow, partic-
ularly in the microvascular bed, in relation to ischemia
induced by mental stress,24,25 and the phenomenon of
endothelial dysfunction induced by mental stress has
been described in CSX.26 Sudden emotional stress can
lead to myocardial stunning in healthy subjects without
CAD, probably owing to exaggerated sympathetic
stimulation that causes vasoconstriction.33 Similarly,
increased sympathetic tone from mental stress can cause
vasoconstriction in patients without coronary disease,
such as in CSX.33,34
The association between endothelial dysfunction
and mental stress in CSX is reported in a SPECT study
by Peix et al.26 CSX patients were asked to focus on an
incident in their lives that made them very angry, and
SPECT imaging was done during this period of mental
stress. A total of 6 out of 16 patients had SPECT-imaged
reversible perfusion defects, and this correlated with
more frequent endothelial dysfunction measured by
brachial artery flow-mediated dilation.
A limitation of the study by Peix et al26 is the non-
standard mental stress test, since it cannot be assumed
that the subjects were exposed to similar levels of mental
stress. We have attempted in our pilot study to avoid this
limitation by using validated standardized questionnaires
for anxiety disorders to measure the anxiety predisposi-
tions and levels of each CSX patient. As mentioned
earlier, state anxiety was measured by the State Scale
(SS) and trait anxiety by the Trait Scale (TS) of the State-
Trait Anxiety Inventory (STAI Dutch version revised by
van der Ploeg, Defares, and Spielberger).29,30
Interestingly, a recent study of CAD patients
showed that mental stress provokes a different myo-
cardial ischemic response compared to exercise or
adenosine.35 However, there is a little data available for
patients groups with normal coronary arteries or syn-
drome X.
There are limited previous data on anxiety disorder
and its relation to endothelial dysfunction. Narita et al36
used brachial artery flow measurements to investigate
anxiety levels and endothelial dysfunction in elderly
males. They found no link between high state anxiety
levels and endothelial dysfunction, but there was a link
for high trait anxiety. This result is broadly similar to
that of our study, in which we showed that CSX patients
Figure 1. Patients with a high trait anxiety had significant
more ischemic segments on SPECT. Mean values ± SEM.
Table 3. Characteristics of patients with high versus low trait anxiety
Patient’s characteristics
High trait
anxiety (n = 6)
Low trait anxiety
(n = 14)
P
value
Age, mean ± SD (years) 55 ± 15 55 ± 9 NS
Woman, % 67 65 NS
Smoker, % 17 14 NS
CAD in family, % 33 78 NS
Time between onset angina and first visit cardiologist,
mean ± SD (years)
2.2 ± 3.9 3.2 ± 9.1 NS
Cardiac drugs, % 33 43 NS
Restricted in daily living due to angina pectoris, % 50 21 NS
Restricted in sport due to chest pain, % 33 21 NS
Chest pain during emotional stress, % 67 21 NS
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with high trait anxiety are at risk of having more
extended ischemia compared to CSX patients with low
trait anxiety.
Reasons for Differences in the State and
Trait Anxiety Results
(1) In our study, the lack of significance in the extent of
ischemia between CSX patients with high and low
state anxiety levels could have two reasons: firstly
the small population of 20 patients, and secondly the
time delay between state anxiety measurements and
SPECT scanning. This latter possibility is because
state anxiety levels may differ at different times.
Obviously, a more definitive study involving a lar-
ger population is needed, whereby myocardial
ischemia is investigated for state and trait anxiety
levels at one time.
(2) A pathophysiological explanation for the different
findings between the state and trait anxiety levels
may be the different effects they have on the
development of ischemia. State anxiety reflects a
transitory emotional condition characterized by
subjective feelings of tension, and is associated
with heightened autonomic nervous system activity.
Trait anxiety, on the other hand, reflects the
existence of a certain predisposition to anxiety. A
high predisposition to anxiety could reflect a chronic
stress condition with long-term high anxiety levels.
In turn, high anxiety levels are most probably a risk
factor for cardiovascular damage only when they are
sustained for long periods.
This hypothesis may also help to explain the results
of Narita et al,36 in particular their result that there was a
significant association between trait anxiety and endo-
thelial dysfunction for elderly males but not for young
ones.
CONCLUSION
This pilot study showed that CSX patients with high
trait anxiety are at risk of having more extended ische-
mia compared to CSX patients with low trait anxiety.
This suggests that anxiety-induced ischemia can occur in
CSX patients, and that high trait anxiety might be a
predisposing risk factor for cardiovascular damage
causing reversible perfusion defects on the SPECT
imaging of CSX patients.
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